Skip to main content
. 2021 Dec 24;2021:1795851. doi: 10.1155/2021/1795851

Table 2.

Factors associated with risk of decompensation on follow-up in patients with cirrhosis of liver.

Without decompensation events n = 73 With decompensation events n = 97 p value
Mean age (mean ± SD, years) 65 ± 11.23 57 ± 10.57 <0.001
Etiology of CLD (n (%))
Alcohol 31 (42.5) 43 (44.3)
Viral hepatitis 9 (12.3) 2 (2.06) 0.043
Cryptogenic 33 (45.2) 52 (53.6)
Comorbidities (n (%))
Diabetes mellitus 56 (76.7) 54 (55.7) 0.004
Systemic hypertension 26 (35.6) 25 (25.8) 0.166
Coronary artery disease 11 (15.1) 8 (8.2) 0.162
Chronic kidney disease 17 (23.3) 13 (13.4) 0.094
Child status (n (%))
Child A 31 (42.5) 6 (6.2)
Child B 15 (20.5) 17 (17.5) <0.001
Child C 27 (37) 74 (76.3)
Mean MELD score (mean ± SD) 17.07 ± 6.5 23.03 ± 6.29 <0.001
Past history of complications of CLD (n (%))
Varices on endoscopy 57 (78.1) 69 (71.1) 0.306
Ascites 1 (1.4) 66 (68) <0.001
Hepatic encephalopathy 0 (0) 41 (42.3) <0.001
Hepatorenal syndrome 0 (0) 45 (46.4) <0.001
Variceal bleed 23 (31.5) 18 (18.6) 0.006
Laboratory parameters (mean ± SD)
Total cholesterol 144.38 ± 43.97 100.19 ± 45.71 0.258
High-density lipoprotein 43.56 ± 13.94 27.58 ± 15.07 <0.001
Low-density lipoprotein 89.89 ± 37.22 61.54 ± 34.61 0.608
Total leucocyte count 5.65 ± 1.85 7.30 ± 5.28 0.048
Platelet count 122.79 ± 65.94 102.85 ± 70.46 0.033
Creatinine 1.19 ± 0.75 1.12 ± 0.70 0.850
Sodium 136.61 ± 3.78 133.55 ± 5.16 0.029
Potassium 4.25 ± 0.54 4.08 ± 0.58 0.427
Albumin 3.52 ± 0.74 2.97 ± 0.61 <0.001
INR 1.34 ± 0.42 1.97 ± 0.81 <0.001
C-reactive protein 11.31 ± 19.60 17.66 ± 25.56 0.080
Neutrophil-lymphocyte ratio (NLR) 2.48 ± 1.53 4.50 ± 4.86 0.003

Statistically significant (<0.05). Abbreviations: CLD: chronic liver disease; MELD score: model for end-stage liver disease; INR: international normalized ratio.